Title |
A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol |
|---|---|
Involved |
Maximilian Mastall (Verfasser)
Patrick Roth (Verfasser) Andrea Bink (Verfasser) Angela Fischer Maranta (Verfasser)
Heinz Läubli (Verfasser)
Andreas Felix Hottinger (Verfasser) Thomas Hundsberger (Verfasser) Denis Migliorini (Verfasser) Adrian Ochsenbein (Verfasser) Katharina Gertrud Seystahl (Verfasser) Lukas Imbach (Verfasser) Tibor Hortobagyi (Verfasser) Leonhard Held (Verfasser) Michael Weller (Verfasser) Hans-Georg Wirsching (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
BMC cancer 24, 1, 15.1.2024, date:12.2024, Seite 1-7 |
Published |
2024 |
Language |
|
Country |
|
Topic |
|
Subject |
Cancer Biology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2024032621312998652895 (URN) |
Record ID |
1324528982 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: